Advances in regulatory B cells in autoimmune thyroid diseases

14Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Regulatory B cells (Bregs) are a subset of B cells that can downregulate the immune and inflammatory responses. The development of B cells in humans and mice is differs. The Positioning and targeted regulation of Bregs has a positive effect on autoimmune diseases. Autoimmune thyroid disease (AITD) is a common autoimmune disease. This review introduces the history and origins of Bregs. It summarizes the different phenotypes and functionalities of Breg cells related to AITD and analyzes the reasons for the differences in Breg expression frequencies in Graves disease (GD) and Hashimoto's Thyroiditis (HT). A number of functional defects of regulatory B cells may be the newly discovered cause of AITD. This paper sheds new light on the role and prospects of Bregs in the progression and treatment of AITD.

Author supplied keywords

Cite

CITATION STYLE

APA

Kang, S., Kang, J., Shen, H., & Wu, N. (2021, July 1). Advances in regulatory B cells in autoimmune thyroid diseases. International Immunopharmacology. Elsevier B.V. https://doi.org/10.1016/j.intimp.2021.107770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free